Abacavir Lamivudin Sandoz
Abacavir Lamivudin Sandoz is a generic from Sandoz Pharmaceuticals AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 268.95 to CHF 268.95 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Sandoz Pharmaceuticals AG
- ATC code
- J05AR02
- IT group
- 08.03 Mittel gegen Viren
- Active substances
- Abacavirum, Lamivudinum
- Preparation type
- Generic
- On the SL since
- 01/09/2020
- Last price change
- 01/12/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 600/300mg | Blist 30 Stk | CHF 232.22 | CHF 268.95 | 01/09/2020 | A | 7680666870013 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Abacavir Lamivudin Sandoz covered by Swiss health insurance?
Yes. Abacavir Lamivudin Sandoz is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Abacavir Lamivudin Sandoz cost in Switzerland?
The public price is the maximum price set by the FOPH and for Abacavir Lamivudin Sandoz ranges from CHF 268.95 to CHF 268.95 per pack. The ex-factory price ranges from CHF 232.22 to CHF 232.22. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages